申请人:——
公开号:US20030225141A1
公开(公告)日:2003-12-04
Compounds of formula I are provided
1
as well as pharmaceutically acceptable salts and esters thereof, wherein R
1
to R
5
, n, m and A have the significance disclosed in the specification, and can be used for the treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders and obesity.
提供了式I的化合物,以及其药学上可接受的盐和酯,其中R1至R5,n,m和A的含义如规范中所披露的那样,并可用于治疗或预防关节炎、心血管疾病、糖尿病、肾衰竭、进食障碍和肥胖症。